Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Head and Neck Neoplasms 3Melanoma 2Glioblastoma 2Brain Neoplasms 2Advanced Solid Tumor 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ulnar Neuropathies 1Triple Negative Breast Neoplasms 1Solid Tumor, Adult 1Prostatic Hyperplasia 1Peripheral Lung Tumor 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Non Squamous Lung Cancer 1Neuroma 1Multiple Myeloma 1Mucositis 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyoma 1Keratosis, Actinic 1Hyperthermia 1Glioma 1

Interventions

pembrolizumab 51Nivolumab 27Gemcitabine 23atezolizumab 19Cisplatin 18Carboplatin 18enfortumab vedotin 15avelumab 15Mitomycin 14Docetaxel 8Ipilimumab 7Paclitaxel 6Injections 5Cyclophosphamide 5vinflunine 4toripalimab 4tislelizumab 4lenvatinib 4fludarabine 4epacadostat 4Pemetrexed 4130-nm albumin-bound paclitaxel 4sacituzumab govitecan 3disitamab vedotin 3Rogaratinib 3Interleukin-2 3ALT-803 3vofatamab 2valrubicin 2rucaparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Transitional Cell × Therapeutics × Clear all
NCT03053635 2018-08-20

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

TheralaseĀ® Technologies Inc.

Phase 1 Completed
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚔